1. Synthesis and Biological Assessment of 4,1-Benzothiazepines with Neuroprotective Activity on the Ca 2+ Overload for the Treatment of Neurodegenerative Diseases and Stroke.
- Author
-
Viejo L, Rubio-Alarcón M, Arribas RL, Moreno-Castro M, Pérez-Marín R, Braun-Cornejo M, Estrada-Valencia M, and de Los Ríos C
- Subjects
- Animals, Calcium metabolism, Calcium Channel Blockers chemical synthesis, Calcium Channel Blockers pharmacology, Calcium Signaling drug effects, Cell Line, Tumor, Female, Humans, Mitochondria, Neurons pathology, Rats, Neurodegenerative Diseases drug therapy, Neurons drug effects, Neuroprotection drug effects, Neuroprotective Agents chemical synthesis, Neuroprotective Agents pharmacology, Stroke drug therapy, Thiazepines chemical synthesis, Thiazepines pharmacology
- Abstract
In excitable cells, mitochondria play a key role in the regulation of the cytosolic Ca
2+ levels. A dysregulation of the mitochondrial Ca2+ buffering machinery derives in serious pathologies, where neurodegenerative diseases highlight. Since the mitochondrial Na+ /Ca2+ exchanger (NCLX) is the principal efflux pathway of Ca2+ to the cytosol, drugs capable of blocking NCLX have been proposed to act as neuroprotectants in neuronal damage scenarios exacerbated by Ca2+ overload. In our search of optimized NCLX blockers with augmented drug-likeness, we herein describe the synthesis and pharmacological characterization of new benzothiazepines analogues to the first-in-class NCLX blocker CGP37157 and its further derivative ITH12575, synthesized by our research group. As a result, we found two new compounds with an increased neuroprotective activity, neuronal Ca2+ regulatory activity and improved drug-likeness and pharmacokinetic properties, such as clog p or brain permeability, measured by PAMPA experiments.- Published
- 2021
- Full Text
- View/download PDF